Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion
Wall Street Journal
Mallinckrodt, the financially troubled pharmaceutical company, is in discussions with a compensation trust for opioid victims as it seeks to potentially reduce the amount of settlement payments by as much as $1 billion, according to people familiar with the matter.